SCHEMBL6617601

SCHEMBL6617601

CC(O)C(NC(=O)C1CCCCN1C(=O)c1csc(-c2ccccc2)n1)C(F)C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPC3 Q13507 1/20 0.41
TRPC6 Q9Y210 1/20 0.41
KCNQ1 P51787 1/20 0.41
ACKR3 P25106 2/20 0.39
CNR2 P34972 2/20 0.38
ACE P12821 1/20 0.38
CNR1 P21554 1/20 0.38
PIN1 Q13526 4/20 0.38
CMA1 P23946 6/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
CHRNA7 P36544 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
NTMT1 Q9BV86 1/20 0.37
HPGDS O60760 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5496923 0.82 PIN1 (0.41) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL5496918 0.82 PIN1 (0.41) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL5498366 0.81 KCNQ1 (0.41) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL5498362 0.81 KCNQ1 (0.41) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL3579231 0.76 PIN1 (0.46) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL5491367 0.76 PIN1 (0.46) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL5491375 0.76 PIN1 (0.46) TRPC3TRPC6KCNQ1ACKR3CNR2
SCHEMBL3539994 0.70 TRPC3 (0.57) TRPC3TRPC6ACKR3CNR2CNR1
SCHEMBL5489939 0.69 ALDH1A1 (0.47) KCNQ1CNR2CNR1PIN1
SCHEMBL5489938 0.69 ALDH1A1 (0.47) KCNQ1CNR2CNR1PIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1381602-A1 HETEROCYCLYLDICARBAMIDES AS CASPASE INHIBITORS Vertex Pharmaceuticals Incorporated (US) 2004-01-21 EP disclosed
WO-2002085899-A1 HETEROCYCLYLDICARBAMIDES AS CASPASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-10-31 WO disclosed